Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
Thick fog has enabled Russian troops to move further into the key strategic city of Pokrovsk...
A surprise visit to Ukraine by actress and humanitarian Angelina Jolie drew scrutiny of her companions,...
The Washington National Opera (WNO) is considering moving out of the Kennedy Center, the company’s home...
